Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 299 | -25,869 | -2,296 | -2,973 | -3,024 |
| Depreciation Amortization | 5 | 1 | N/A | N/A | N/A |
| Accounts receivable | -1,677 | 0 | N/A | N/A | 1 |
| Other Working Capital | -512 | 689 | -224 | 738 | -598 |
| Other Operating Activity | -1,217 | 22,733 | 597 | 422 | 542 |
| Operating Cash Flow | $-3,102 | $-2,446 | $-1,923 | $-1,813 | $-3,079 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -525 | N/A |
| PPE Investments | N/A | -7 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | 751 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 175 | 0 |
| Investing Cash Flow | $N/A | $-7 | $751 | $-350 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 3 | 372 | N/A |
| Debt Issued | N/A | 0 | 375 | 625 | N/A |
| Common Stock Issued | 1,276 | 4,373 | 1,500 | N/A | 2,021 |
| Other Financing Activity | -11 | -211 | -459 | -162 | -539 |
| Financing Cash Flow | $1,265 | $4,162 | $1,419 | $835 | $1,482 |
| Beginning Cash Position | 2,355 | 646 | 399 | 1,727 | 3,324 |
| End Cash Position | 518 | 2,355 | 646 | 399 | 1,727 |
| Net Cash Flow | $-1,839 | $1,709 | $247 | $-1,328 | $-1,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,102 | -2,446 | -1,923 | -1,813 | -3,079 |
| Capital Expenditure | N/A | -7 | N/A | N/A | N/A |
| Free Cash Flow | -3,102 | -2,453 | -1,923 | -1,813 | -3,079 |